CLDX
Celldex Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow -2.5% ·
net new positions -9.1%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +8 | 50.70M | $1.89B | +11 | −3 |
| Q1 2026 | 82 | +10 | 42.54M | $1.35B | +12 | −2 |
| Q4 2025 | 72 | 0 | 42.78M | $1.16B | — | — |
| Q3 2025 | 17 | 0 | 35.45M | $917.00M | — | — |
| Q2 2025 | 14 | 0 | 33.46M | $680.97M | — | — |
| Q1 2025 | 11 | -1 | 21.24M | $385.48M | — | −1 |
| Q4 2024 | 12 | +1 | 21.78M | $550.46M | +2 | −1 |
| Q3 2024 | 10 | -1 | 17.69M | $601.30M | — | −1 |
| Q2 2024 | 11 | — | 17.48M | $646.94M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.35M | -6.9% | $151.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.41M | -4.1% | $61.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.41M | -4.1% | $61.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passive) | 2.81M | -13.2% | $50.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 2.62M | +4.2% | $47.57M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 1.59M | +3.6% | $28.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 1.59M | +3.6% | $28.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 871.63K | +92.6% | $15.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 603.40K | -14.8% | $10.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 603.40K | -14.8% | $10.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 406.16K | -21.6% | $7.37M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 406.16K | -21.6% | $7.37M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Millennium Management ✦ | 399.93K | +327.3% | $7.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 146.59K | +7.3% | $2.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 28.66K | -13.2% | $520,106 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| AQR Capital Management | $548,965 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 227 holders, 72.32M shares, $2.21B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.